Loading clinical trials...
Loading clinical trials...
The Clinical Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol in a Single Inhaler (TRELEGY™ ELLIPTA™) When Compared With Non-ELLIPTA Multiple Inhaler Triple Therapies in COPD Patients Within a Usual Care Setting
Conditions
Interventions
FF/UMEC/VI
Inhaled Corticosteroid
+3 more
Locations
143
Germany
GSK Investigational Site
Aschaffenburg, Bavaria, Germany
GSK Investigational Site
Dachau, Bavaria, Germany
GSK Investigational Site
Garmisch-Partenirchen, Bavaria, Germany
GSK Investigational Site
Wallerfing, Bavaria, Germany
GSK Investigational Site
Cottbus, Brandenburg, Germany
GSK Investigational Site
Fürstenwalde, Brandenburg, Germany
Start Date
April 11, 2018
Primary Completion Date
October 10, 2019
Completion Date
October 10, 2019
Last Updated
September 7, 2020
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions